• Record monthly sales of A$11.9m, up 71.1% on STLY
• U.S. sales up 92.6% to A$9.3m, with 54 new accounts added
• U.K. sales up 139.8% to A$0.9m, with first ever £1m quarter

PolyNovo Limited (PolyNovo or Company) had record monthly sales of A$11.9m (unaudited) and total revenue of A$12.4m (unaudited) for March 2025. The Group saw record monthly sales, with the U.S. recording A$9.3m, up 92.6% on the prior year, and the U.K. recording A$0.9m, up 139.8%. The company continued to expand its account base, adding 54 new accounts in the U.S. during the quarter. In the U.K., PolyNovo achieved its first ever £1m quarter, with total sales of A$2.1m, up 73.6% on the prior year. India also saw strong growth, with monthly sales of A$133k, up 97.2% on the prior year. The company's total monthly group revenue, including BARDA, was A$12.4m, up 48.5% on the prior year. PolyNovo remains profitable, with results in line with internal plans, and has appropriate cash reserves and operating cash flow to fund the remaining capex for the new manufacturing facility and R&D innovation centre.

The Chairman of PolyNovo, David Williams said: 'we have an enviable array of ways to expand indications in existing markets, expand our international footprint, and introduce new products to drive revenue growth.'